Post-COVID-19 GI Manifestations: Are We in for the “Long Haul”? Volume 3 - Issue 2

Kevin V Houston, Byung Soo Yoo, Steve D Souza, James Lau, Alsiddig Elmahdi, Parth J Parekh and David Johnson*

• Department of Gastroenterology, Eastern Virginia Medical School, Norfolk, Virginia

Received:June 19, 2021   Published: June 29, 2021

*Corresponding author:David Johnson, Professor of Medicine, Chief of Gastroenterology, Eastern Virginia Medical School, Norfolk, Virginia

DOI: 10.32474/CTGH.2021.03.000158

 

Fulltext PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Post-COVID-19 gastrointestinal (GI) disease management remains a clinical challenge as the medical literature continues to evolve and expand. Reports of excess GI disease burden across the population, as well as prescribed use of pharmaceuticals for symptom relief, have proven “long-haul” GI disease is prevalent across the population. This article will help to summarize the current medical literature as it pertains to post-COVID-19 GI clinical presentations, dysbiosis, functional disorders and evidence of lasting liver and biliary injury implications. Increased awareness of the GI implications for this paradigm hopefully will lead to a better understanding of the pathophysiology, as well as natural history and potential therapeutic approaches.

Keywords:COVID-19; post-covid manifestations; long covid; gastrointestinal disorders; dysbiosis; dyspepsia; microbiome; probiotics

Abstract| Background| Statistical Analysis| Results| Discussion| Conclusion| What Is Known| Relevance of the study| Abbreviations and acronyms| Declarations| References|